Efficacy News and Research

RSS
Women say California insurer makes it too hard to get drug for postpartum depression

Women say California insurer makes it too hard to get drug for postpartum depression

Immunity to SARS-CoV-2 in renal transplant and dialysis patients using Pfizer/BioNTech and Moderna vaccines

Immunity to SARS-CoV-2 in renal transplant and dialysis patients using Pfizer/BioNTech and Moderna vaccines

Impaired immune response to SARS-CoV-2 mRNA vaccination in immunocompromised patients

Impaired immune response to SARS-CoV-2 mRNA vaccination in immunocompromised patients

Gateway for Cancer Research funds EORTC 1634-BTG trial in post-pubertal brain tumor patients

Gateway for Cancer Research funds EORTC 1634-BTG trial in post-pubertal brain tumor patients

Umbilical cord-derived mesenchymal stem cells show promise to treat muscular dystrophies

Umbilical cord-derived mesenchymal stem cells show promise to treat muscular dystrophies

3D-bioprinted cardiac patches show therapeutic, regenerative potential for treating ischemic cardiomyopathy

3D-bioprinted cardiac patches show therapeutic, regenerative potential for treating ischemic cardiomyopathy

Monoclonal antibody CT-P59 demonstrates potent antiviral efficacy against SARS-CoV-2 delta variant

Monoclonal antibody CT-P59 demonstrates potent antiviral efficacy against SARS-CoV-2 delta variant

One dose of mRNA vaccine reduced COVID risk for at least four months in health care workers

One dose of mRNA vaccine reduced COVID risk for at least four months in health care workers

CDC study on efficacy of mRNA vaccines against symptomatic COVID-19

CDC study on efficacy of mRNA vaccines against symptomatic COVID-19

Researchers develop new exosome formulation to deliver VEGF antibodies for synergistic therapy

Researchers develop new exosome formulation to deliver VEGF antibodies for synergistic therapy

More popular type of antihypertensive drugs causes slightly more side effects

More popular type of antihypertensive drugs causes slightly more side effects

Study compares mRNA and adenovirus-based SARS-CoV-2 vaccines against variants of concern

Study compares mRNA and adenovirus-based SARS-CoV-2 vaccines against variants of concern

Brain’s locus coeruleus may be a sophisticated regulator of learning and behavior

Brain’s locus coeruleus may be a sophisticated regulator of learning and behavior

Rosin soap as a potential SARS-CoV-2 disinfectant

Rosin soap as a potential SARS-CoV-2 disinfectant

Activation of integrins by SARS-CoV-2 may be key to infection

Activation of integrins by SARS-CoV-2 may be key to infection

Novel therapeutic agent could be effective for treating cancers with certain gene mutations

Novel therapeutic agent could be effective for treating cancers with certain gene mutations

MUSC Hollings Cancer Center part of promising phase 2 lymphoma clinical trial

MUSC Hollings Cancer Center part of promising phase 2 lymphoma clinical trial

Clinical trials during a pandemic – lessons from COVID-19

Clinical trials during a pandemic – lessons from COVID-19

Facing headwinds on new Alzheimer’s drug, Biogen launches controversial campaign

Facing headwinds on new Alzheimer’s drug, Biogen launches controversial campaign

Aptamer Group and WuXi AppTec Research Service Division collaborate to identify new Optimer™ enabled therapeutics

Aptamer Group and WuXi AppTec Research Service Division collaborate to identify new Optimer™ enabled therapeutics

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.